Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy
A relevant number of recurrences qualifies as oligometastatic according to the ESTRO-ASTRO consensus, which associate with improved prognosis irrespective of the type of recurrence therapy. Patients experiencing oligometastatic recurrence should be carefully evaluated for potentially curative treatment approaches.
Authors
- Johannes Knoth (ORCID: https://orcid.org/0000-0002-0704-9910)
- Christoph Grimm (ORCID: https://orcid.org/0000-0003-2948-8129)
- Maximilian Schmid (ORCID: https://orcid.org/0000-0003-1525-6423)
- Alina Sturdza (ORCID: https://orcid.org/0000-0002-0527-564X)
- Tim Dorittke (ORCID: https://orcid.org/0000-0002-9121-3401)
- Thomas Bartl (ORCID: https://orcid.org/0000-0002-1938-1574)
- Cristina Ciocsirescu
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3802/jgo.2025.36.e99
- Citations
- 2
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.11